KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $360,000 | +8.1% | 50,732 | +10.2% | 0.00% | 0.0% |
| Q2 2017 | $333,000 | +17.7% | 46,018 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $283,000 | -2.7% | 46,018 | -7.3% | 0.00% | 0.0% |
| Q4 2016 | $291,000 | +5.4% | 49,640 | -4.6% | 0.00% | 0.0% |
| Q3 2016 | $276,000 | -19.8% | 52,010 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $344,000 | +11.7% | 52,010 | -21.0% | 0.00% | 0.0% |
| Q1 2016 | $308,000 | -11.2% | 65,868 | -4.2% | 0.00% | 0.0% |
| Q4 2015 | $347,000 | +47.0% | 68,725 | +2.6% | 0.00% | 0.0% |
| Q3 2015 | $236,000 | -64.7% | 66,976 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $668,000 | -29.2% | 66,976 | -9.6% | 0.00% | -25.0% |
| Q1 2015 | $943,000 | -4.1% | 74,077 | +6.7% | 0.00% | 0.0% |
| Q4 2014 | $983,000 | +1.7% | 69,439 | -1.3% | 0.00% | 0.0% |
| Q3 2014 | $967,000 | -10.5% | 70,342 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $1,081,000 | -78.9% | 70,288 | -76.6% | 0.00% | -83.3% |
| Q1 2014 | $5,122,000 | +84.0% | 300,581 | +39.8% | 0.02% | +100.0% |
| Q4 2013 | $2,783,000 | +324.2% | 214,939 | +230.8% | 0.01% | +300.0% |
| Q3 2013 | $656,000 | +42.3% | 64,985 | +5.3% | 0.00% | +50.0% |
| Q2 2013 | $461,000 | – | 61,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |